Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002

Author： Bottone Frank G. Barry William T.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.6, 2009-06, pp. : 1535-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-market surveillance to detect adverse events associated with Melody^® valve implantation

Cardiology in the Young, Vol. 27, Iss. 6, 2016-11 ,pp. : 1090-1097

Cambridge University Press

Access to resources Recommend Favorite

Factors contributing to serious adverse events in nursing homes

JOURNAL OF CLINICAL NURSING, Vol. 27, Iss. 1-2, 2018-01 ,pp. : e354-e362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review

Current Drug Safety, Vol. 6, Iss. 3, 2011-07 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse Drug Events Among Hospitalized Medicare Patients: Epidemiology and National Estimates from a New Approach to Surveillance

By Classen David C. Jaser Lisa Budnitz Daniel S.

Joint Commission Journal on Quality and Patient Safety, Vol. 36, Iss. 1, 2010-01 ,pp. : 12-0

Joint Commission Resources

Access to resources Recommend Favorite

The effect of critical care outreach on postoperative serious adverse events

ANAESTHESIA, Vol. 59, Iss. 8, 2004-08 ,pp. : 762-766

John Wiley & Sons Inc

Access to resources Recommend Favorite